Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Pictilisib dimethanesulfonate
Cat. No.:
OB0225LY-0453
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Pictilisib dimethanesulfonate is a selective PI3K inhibitor, mainly used in the study of tumor-related signaling pathways.
Synonym:
GDC-0941 dimethanesulfonate; GDC-0941 2 MeSO3H salt; 957054-33-0; GDC-0941 Bimesylate; 4-[2-(1H-Indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine methanesulfonic acid; 4-(2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine dimethanesulfonate
CAS No.:
957054-33-0
Compound CID:
56972143
Formula:
C25H35N7O9S4
Formula Weight:
705.85
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Pictilisib dimethanesulfonate can be used for cancer cell proliferation studies.
Library Information
Targets:
Lipid kinases (PI3K class I); PIKK family kinases
Receptors:
DNA-PK; mTOR; p110α; p110α-E545K; p110α-H1047R; p110β; p110γ; p110δ; PI3K
Pathways:
DNA damage/DNA repair; Apoptosis; Autophagy; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-6
Plate Location:
g10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 70.84 mM
Water Max Solubility:
<0.1 mg/mL (insoluble)
